Published in J Virol on February 23, 2011
Immunogenetic mechanisms driving norovirus GII.4 antigenic variation. PLoS Pathog (2012) 2.02
Recombination within the pandemic norovirus GII.4 lineage. J Virol (2013) 1.93
Genetic mapping of a highly variable norovirus GII.4 blockade epitope: potential role in escape from human herd immunity. J Virol (2011) 1.53
Structural analysis of histo-blood group antigen binding specificity in a norovirus GII.4 epidemic variant: implications for epochal evolution. J Virol (2011) 1.53
A Unique Human Norovirus Lineage with a Distinct HBGA Binding Interface. PLoS Pathog (2015) 1.49
Epidemiology of human noroviruses and updates on vaccine development. Curr Opin Gastroenterol (2014) 1.49
Emergence of new pandemic GII.4 Sydney norovirus strain correlates with escape from herd immunity. J Infect Dis (2013) 1.47
Norovirus. Clin Microbiol Rev (2015) 1.41
Norovirus immunity and the great escape. PLoS Pathog (2012) 1.40
Rapid emergence and predominance of a broadly recognizing and fast-evolving norovirus GII.17 variant in late 2014. Nat Commun (2015) 1.40
Emergence of a norovirus GII.4 strain correlates with changes in evolving blockade epitopes. J Virol (2012) 1.36
Crystallography of a Lewis-binding norovirus, elucidation of strain-specificity to the polymorphic human histo-blood group antigens. PLoS Pathog (2011) 1.31
Monoclonal antibody-based antigenic mapping of norovirus GII.4-2002. J Virol (2011) 1.29
Structural basis for norovirus inhibition and fucose mimicry by citrate. J Virol (2011) 1.05
Host genetic factors affect susceptibility to norovirus infections in Burkina Faso. PLoS One (2013) 1.04
Multiple antigenic sites are involved in blocking the interaction of GII.4 norovirus capsid with ABH histo-blood group antigens. J Virol (2012) 1.02
Norovirus Infection and Disease in an Ecuadorian Birth Cohort: Association of Certain Norovirus Genotypes With Host FUT2 Secretor Status. J Infect Dis (2014) 1.01
Deep sequencing of norovirus genomes defines evolutionary patterns in an urban tropical setting. J Virol (2014) 0.94
An outbreak caused by GII.17 norovirus with a wide spectrum of HBGA-associated susceptibility. Sci Rep (2015) 0.94
Gangliosides are ligands for human noroviruses. J Am Chem Soc (2014) 0.90
Absolute Humidity Influences the Seasonal Persistence and Infectivity of Human Norovirus. Appl Environ Microbiol (2014) 0.90
Two gastroenteritis outbreaks caused by GII Noroviruses: host susceptibility and HBGA phenotypes. PLoS One (2013) 0.89
Noroviral p-particles as an in vitro model to assess the interactions of noroviruses with probiotics. PLoS One (2014) 0.88
Inhibition of histo-blood group antigen binding as a novel strategy to block norovirus infections. PLoS One (2013) 0.86
Affinities of recombinant norovirus P dimers for human blood group antigens. Glycobiology (2012) 0.86
Temporal dynamics of norovirus GII.4 variants in Brazil between 2004 and 2012. PLoS One (2014) 0.85
Chimeric GII.4 norovirus virus-like-particle-based vaccines induce broadly blocking immune responses. J Virol (2014) 0.83
Evidence for human norovirus infection of dogs in the United kingdom. J Clin Microbiol (2015) 0.82
Innate Resistance and Susceptibility to Norovirus Infection. PLoS Pathog (2016) 0.81
Affinities of human histo-blood group antigens for norovirus capsid protein complexes. Glycobiology (2014) 0.81
Control and prevention of viral gastroenteritis. Emerg Infect Dis (2011) 0.81
Blood group substances as potential therapeutic agents for the prevention and treatment of infection with noroviruses proving novel binding patterns in human tissues. PLoS One (2014) 0.78
Crystal structures of GI.8 Boxer virus P dimers in complex with HBGAs, a novel evolutionary path selected by the Lewis epitope. Protein Cell (2014) 0.77
Molecular characterization of noroviruses and HBGA from infected Quilombola children in Espirito Santo State, Brazil. PLoS One (2013) 0.77
Shared human/rabbit ligands for rabbit hemorrhagic disease virus. Emerg Infect Dis (2012) 0.77
Personalized genetic testing and norovirus susceptibility. Can J Infect Dis Med Microbiol (2014) 0.75
Norovirus drug candidates that inhibit viral capsid attachment to human histo-blood group antigens. Antiviral Res (2016) 0.75
Llama nanoantibodies with therapeutic potential against human norovirus diarrhea. PLoS One (2015) 0.75
Temporal Evolutionary Dynamics of Norovirus GII.4 Variants in China between 2004 and 2015. PLoS One (2016) 0.75
Antibodies against Lewis antigens inhibit the binding of human norovirus GII.4 virus-like particles to saliva but not to intestinal Caco-2 cells. Virol J (2016) 0.75
Human sera collected during 1979-2010 possess blocking antibody titers to pandemic GII.4 noroviruses isolated during 3 decades. J Virol (2017) 0.75
Visualization by immune electron microscopy of a 27-nm particle associated with acute infectious nonbacterial gastroenteritis. J Virol (1972) 9.12
Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein. J Virol (1992) 8.35
Norovirus classification and proposed strain nomenclature. Virology (2005) 7.69
Human susceptibility and resistance to Norwalk virus infection. Nat Med (2003) 7.07
X-ray crystallographic structure of the Norwalk virus capsid. Science (1999) 6.58
Mechanisms of GII.4 norovirus persistence in human populations. PLoS Med (2008) 4.57
Norovirus illness is a global problem: emergence and spread of norovirus GII.4 variants, 2001-2007. J Infect Dis (2009) 4.25
Norwalk virus binds to histo-blood group antigens present on gastroduodenal epithelial cells of secretor individuals. Gastroenterology (2002) 4.13
Noroviruses bind to human ABO, Lewis, and secretor histo-blood group antigens: identification of 4 distinct strain-specific patterns. J Infect Dis (2003) 4.03
Norovirus and histo-blood group antigens: demonstration of a wide spectrum of strain specificities and classification of two major binding groups among multiple binding patterns. J Virol (2005) 3.74
Epochal evolution of GGII.4 norovirus capsid proteins from 1995 to 2006. J Virol (2007) 3.71
Structural basis for the recognition of blood group trisaccharides by norovirus. J Virol (2007) 3.58
Norovirus and its histo-blood group antigen receptors: an answer to a historical puzzle. Trends Microbiol (2005) 3.00
Mutations within the P2 domain of norovirus capsid affect binding to human histo-blood group antigens: evidence for a binding pocket. J Virol (2003) 2.82
Rapid evolution of pandemic noroviruses of the GII.4 lineage. PLoS Pathog (2010) 2.80
Evolutionary dynamics of GII.4 noroviruses over a 34-year period. J Virol (2009) 2.74
The P domain of norovirus capsid protein forms dimer and binds to histo-blood group antigen receptors. J Virol (2004) 2.68
Atomic resolution structural characterization of recognition of histo-blood group antigens by Norwalk virus. Proc Natl Acad Sci U S A (2008) 2.54
Norwalk virus infection associates with secretor status genotyped from sera. J Med Virol (2005) 2.34
A predominant role for Norwalk-like viruses as agents of epidemic gastroenteritis in Maryland nursing homes for the elderly. J Infect Dis (2002) 2.33
The p domain of norovirus capsid protein forms a subviral particle that binds to histo-blood group antigen receptors. J Virol (2005) 2.29
ABH and Lewis histo-blood group antigens, a model for the meaning of oligosaccharide diversity in the face of a changing world. Biochimie (2001) 2.23
Molecular epidemiology of genogroup II-genotype 4 noroviruses in the United States between 1994 and 2006. J Clin Microbiol (2009) 2.06
Norovirus gastroenteritis, carbohydrate receptors, and animal models. PLoS Pathog (2010) 2.02
Norovirus pathogenesis: mechanisms of persistence and immune evasion in human populations. Immunol Rev (2008) 1.96
Phylodynamic reconstruction reveals norovirus GII.4 epidemic expansions and their molecular determinants. PLoS Pathog (2010) 1.88
Noroviral P particle: structure, function and applications in virus-host interaction. Virology (2008) 1.75
Mutation in a Lordsdale norovirus epidemic strain as a potential indicator of transmission routes. J Clin Microbiol (2004) 1.66
Ganglioside-linked terminal sialic acid moieties on murine macrophages function as attachment receptors for murine noroviruses. J Virol (2009) 1.61
Elucidation of strain-specific interaction of a GII-4 norovirus with HBGA receptors by site-directed mutagenesis study. Virology (2008) 1.54
Herd immunity to GII.4 noroviruses is supported by outbreak patient sera. J Virol (2009) 1.51
Influence of the combined ABO, FUT2, and FUT3 polymorphism on susceptibility to Norwalk virus attachment. J Infect Dis (2005) 1.50
Neonatal protection by an innate immune system of human milk consisting of oligosaccharides and glycans. J Anim Sci (2008) 1.49
Characterisation of a GII-4 norovirus variant-specific surface-exposed site involved in antibody binding. Virol J (2009) 1.39
Characterization of capsid genes, expressed in the baculovirus system, of three new genetically distinct strains of "Norwalk-like viruses". J Clin Microbiol (2001) 1.37
Human noroviruses recognize sialyl Lewis x neoglycoprotein. Glycobiology (2008) 1.35
Lewis blood group-related antigen expression in normal gastric epithelium, intestinal metaplasia, gastric adenoma, and gastric carcinoma. Am J Gastroenterol (1993) 1.33
Predominance and circulation of enteric viruses in the region of Greater Cairo, Egypt. J Clin Microbiol (2009) 1.27
Norwalk virus assembly and stability monitored by mass spectrometry. Mol Cell Proteomics (2010) 1.26
Identification of the sialic acid structures recognized by minute virus of mice and the role of binding affinity in virulence adaptation. J Biol Chem (2006) 1.17
Genogroup II noroviruses efficiently bind to heparan sulfate proteoglycan associated with the cellular membrane. J Virol (2004) 1.16
Evidence of emergence of new GGII.4 norovirus variants from gastroenteritis outbreak survey in France during the 2007-to-2008 and 2008-to-2009 winter seasons. J Clin Microbiol (2009) 1.15
Divergent evolution of norovirus GII/4 by genome recombination from May 2006 to February 2009 in Japan. J Virol (2010) 1.07
Expression of blood group-related antigens, ABH, Lewis(a), Lewis(b), Lewis(x), Lewis(y), CA19-9, and CSLEX1 in early cancer, intestinal metaplasia, and uninvolved mucosa of the stomach. Am J Clin Pathol (1992) 1.01
Revisited BIA-MS combination: entire "on-a-chip" processing leading to the proteins identification at low femtomole to sub-femtomole levels. Biosens Bioelectron (2008) 0.96
Molecular cloning, expression, self-assembly, antigenicity, and seroepidemiology of a genogroup II norovirus isolated in France. J Clin Microbiol (2003) 0.93
Inhibition of protein adsorption to muscovite mica by monovalent cations. J Microsc (2003) 0.84
Glycosylation features of gastric carcinoma initiation and progression. A review with emphasis on simple mucin-type carbohydrates and histo-blood group antigens of the Lewis system. Eur J Cancer Prev (1994) 0.81
The epidemiology of enteric caliciviruses from humans: a reassessment using new diagnostics. J Infect Dis (2000) 3.29
Prevalence of group A rotavirus, human calicivirus, astrovirus, and adenovirus type 40 and 41 infections among children with acute gastroenteritis in Dijon, France. J Clin Microbiol (1999) 2.70
Atomic structure of the major capsid protein of rotavirus: implications for the architecture of the virion. EMBO J (2001) 2.43
Prevalence and genetic diversity of Aichi virus strains in stool samples from community and hospitalized patients. J Clin Microbiol (2008) 2.42
Effect of filgrastim treatment on inflammatory cytokines and lymphocyte functions. Clin Pharmacol Ther (1999) 2.33
ABH and Lewis histo-blood group antigens, a model for the meaning of oligosaccharide diversity in the face of a changing world. Biochimie (2001) 2.23
The mechanism of respiratory failure in paraneoplastic pemphigus. N Engl J Med (1999) 2.21
Strategy to detect and identify Bartonella species in routine clinical laboratory yields Bartonella henselae from human immunodeficiency virus-positive patient and unique Bartonella strain from his cat. J Clin Microbiol (1995) 2.06
Monoclonal antibodies against respiratory syncytial virus and their use for rapid detection of virus in nasopharyngeal secretions. J Clin Microbiol (1985) 1.96
Analysis of integrated virological and epidemiological reports of norovirus outbreaks collected within the Foodborne Viruses in Europe network from 1 July 2001 to 30 June 2006. J Clin Microbiol (2008) 1.80
An inequality among determinants. Proc Natl Acad Sci U S A (1975) 1.74
Frequencies of CD4+ T cells reactive with Plasmodium chabaudi chabaudi: distinct response kinetics for cells with Th1 and Th2 characteristics during infection. Int Immunol (1989) 1.68
Genetics of ABO, H, Lewis, X and related antigens. Vox Sang (1986) 1.67
Comparison of two new tests for rapid diagnosis of respiratory syncytial virus infections by enzyme-linked immunosorbent assay and immunofluorescence techniques. J Clin Microbiol (1986) 1.61
Multiple 3' ends of the chicken pro alpha 2(I) collagen gene. Nucleic Acids Res (1983) 1.61
Pyrazinamide is not active against Mycobacterium tuberculosis residing in cultured human monocyte-derived macrophages. Int J Tuberc Lung Dis (2000) 1.58
Identification of the hemolysis-associated protein 1 as a cross-protective immunogen of Leptospira interrogans by adenovirus-mediated vaccination. Infect Immun (2001) 1.56
Gastric mucosa during treatment with lansoprazole: Helicobacter pylori is a risk factor for argyrophil cell hyperplasia. Gastroenterology (1997) 1.56
Pancreatic gastrin stimulates islet differentiation of transforming growth factor alpha-induced ductular precursor cells. J Clin Invest (1993) 1.55
An interleukin 2/sodium butyrate combination as immunotherapy for rat colon cancer peritoneal carcinomatosis. Gastroenterology (1994) 1.49
Binding of rabbit hemorrhagic disease virus to antigens of the ABH histo-blood group family. J Virol (2000) 1.49
A new family of polymorphic genes in Saccharomyces cerevisiae: alpha-galactosidase genes MEL1-MEL7. Mol Gen Genet (1990) 1.45
The ecology of social relationships in housing for the elderly. Gerontologist (1968) 1.45
Comparison of activities of rifapentine and rifampin against Mycobacterium tuberculosis residing in human macrophages. Antimicrob Agents Chemother (1995) 1.43
Rotavirus genotypes co-circulating in Europe between 2006 and 2009 as determined by EuroRotaNet, a pan-European collaborative strain surveillance network. Epidemiol Infect (2010) 1.42
24 hour intragastric acidity and single night-time dose of three H-2-blockers. Lancet (1983) 1.41
Increase in norovirus activity reported in Europe. Euro Surveill (2006) 1.41
[The return of the GAS Mask. Reply of P. Berthelot, J.-C. Lucet, S. Aho, J. Hajjar to the article by O. Multon ]. Gynecol Obstet Fertil (2008) 1.40
Reduced fungal contamination of the indoor environment with the Plasmair system (Airinspace). J Hosp Infect (2006) 1.39
Immunohistologic pattern of type 1 (Lea, Leb) and type 2 (X, Y, H) blood group-related antigens in the human pyloric and duodenal mucosae. Lab Invest (1985) 1.36
Dynamics of P. falciparum gametocytemia in symptomatic patients in an area of intense perennial transmission in Tanzania. Am J Trop Med Hyg (2001) 1.34
Molecular epidemiology of caliciviruses detected in sporadic and outbreak cases of gastroenteritis in France from December 1998 to February 2004. J Clin Microbiol (2005) 1.34
Large artery remodeling during aging: biaxial passive and active stiffness. Hypertension (1998) 1.33
Characterization of new recombinant noroviruses. J Clin Microbiol (2005) 1.33
[Healing rates following omeprazole and ranitidine treatment of gastric ulcer. Results of a German multicenter study]. Dtsch Med Wochenschr (1985) 1.31
The members of the plakin family of proteins recognized by paraneoplastic pemphigus antibodies include periplakin. J Invest Dermatol (1998) 1.30
Heparin-like structures on respiratory syncytial virus are involved in its infectivity in vitro. J Virol (1998) 1.29
Comparative genotyping of Candida albicans bloodstream and nonbloodstream isolates at a polymorphic microsatellite locus. J Clin Microbiol (2000) 1.27
The structure of the chicken alpha 2 collagen gene. Ann N Y Acad Sci (1985) 1.27
Infection by Helicobacter pylori expressing the BabA adhesin is influenced by the secretor phenotype. J Pathol (2008) 1.26
G and P genotyping of rotavirus strains circulating in france over a three-year period: detection of G9 and P[6] strains at low frequencies. The AZAY Group. J Clin Microbiol (2000) 1.24
Modification of osteoarthritis by pulsed electromagnetic field--a morphological study. Osteoarthritis Cartilage (2003) 1.23
Inhibition of mitochondrial ATP generation by nitric oxide switches apoptosis to necrosis. Exp Cell Res (1999) 1.23
Use of a simple method for the Epstein-Barr virus transformation of lymphocytes from members of large families of Réunion Island. Hum Hered (1988) 1.18
Evidence of emergence of new GGII.4 norovirus variants from gastroenteritis outbreak survey in France during the 2007-to-2008 and 2008-to-2009 winter seasons. J Clin Microbiol (2009) 1.15
[Adult respiratory distress syndrome. Two post-operative cases (author's transl)]. Anesth Analg (Paris) (1981) 1.14
Treatment of neuroendocrine GEP tumours with somatostatin analogues: a review. Digestion (2000) 1.14
Comparison of cell culture with two direct Chlamydia tests using immunofluorescence or enzyme-linked immunosorbent assay. Eur J Clin Microbiol (1986) 1.13
Migration of fetal intestinal intervillous cells in neonatal mice. Anat Rec (1990) 1.12
Effect of repeated, once daily, oral omeprazole on gastric secretion. Lancet (1983) 1.12
Mutations of the DPC4/Smad4 gene in neuroendocrine pancreatic tumors. Oncogene (1999) 1.10
Evaluation of the VA's Pilot Program in Institutional Reorganization toward Primary and Ambulatory Care: Part I, Changes in process and outcomes of care. Acad Med (1996) 1.10
Immunochemical characterization of mucins. Polypeptide (M1) and polysaccharide (A and Leb) antigens. Biochem J (1988) 1.09
Molecular cloning of major and minor allergens of Alternaria alternata and Cladosporium herbarum. Mol Immunol (1995) 1.09
The protein core of the proteoglycan perlecan binds specifically to fibroblast growth factor-7. J Biol Chem (2000) 1.08
Data quality of 5 years of central norovirus outbreak reporting in the European Network for food-borne viruses. J Public Health (Oxf) (2007) 1.08
Increasing the impact of quality improvement on health: an expert panel method for setting institutional priorities. Jt Comm J Qual Improv (1995) 1.07
HCO 3 -stimulated ATPase from mammalian pancreas. Properties and its arrangement with other enzyme activities. Biochim Biophys Acta (1972) 1.07
Rotavirus surveillance in europe, 2005-2008: web-enabled reporting and real-time analysis of genotyping and epidemiological data. J Infect Dis (2009) 1.06
Pulsed electromagnetic fields simultaneously induce osteogenesis and upregulate transcription of bone morphogenetic proteins 2 and 4 in rat osteoblasts in vitro. Biochem Biophys Res Commun (1998) 1.06
Human fat cell adenylate cyclase: regional differences in adrenaline responsiveness. Eur J Clin Invest (1977) 1.06
Pulsed electromagnetic field stimulation of MG63 osteoblast-like cells affects differentiation and local factor production. J Orthop Res (2000) 1.05
Human gastric acid secretion following repeated doses of AG-1749. Aliment Pharmacol Ther (1989) 1.03
Antibody inhibition of the transcriptase activity of the rotavirus DLP: a structural view. J Mol Biol (2001) 1.03
An accelerated vaccine schedule with a poly-antigenic hepatitis C virus MVA-based candidate vaccine induces potent, long lasting and in vivo cross-reactive T cell responses. Vaccine (2007) 1.02
Cephalosporin and fluoroquinolone combinations are highly associated with CTX-M β-lactamase-producing Escherichia coli: a case-control study in a French teaching hospital. Clin Microbiol Infect (2011) 1.02
Synthesis of ganglioside GD3 and its comparison with bovine GD3 with regard to oligodendrocyte apoptosis mitochondrial damage. Chemistry (2001) 1.01
Dose-related healing of duodenal ulcer with the proton pump inhibitor lansoprazole. Aliment Pharmacol Ther (1991) 1.01
Analysis of beta-catenin gene mutations in pancreatic tumors. Digestion (2000) 1.01
A structure refinement protocol combining NMR residual dipolar couplings and small angle scattering restraints. J Biomol NMR (2008) 1.01
Loss of microtubules and alteration of glycoprotein migration in organ cultures of mouse intestine exposed to nocodazole or colchicine. Cell Tissue Res (1987) 1.00
Distribution of H type 1 and H type 2 antigenic determinants in human sera and saliva. Am J Hum Genet (1982) 0.99
Co-segregation of tumor immunogenicity with expression of inducible but not constitutive hsp70 in rat colon carcinomas. J Immunol (1995) 0.99
Alpha1-antitrypsin deficiency with M-like phenotype. J Med Genet (1977) 0.99
Identification of ethanol-intoxicated patients with minor head trauma requiring computed tomography scans. Acad Emerg Med (1995) 0.99
H blood group antigen carried by CD44V modulates tumorigenicity of rat colon carcinoma cells. Cancer Res (1994) 0.99
Crystallization and preliminary X-Ray analysis of rotavirus protein VP6. J Virol (1998) 0.98
Proposed recommendations for the management of HIV post-exposure prophylaxis after sexual, injecting drug or other exposures in Europe. Euro Surveill (2004) 0.97
Topology of bovine rotavirus (RF strain) VP6 epitopes by real-time biospecific interaction analysis. Virology (1994) 0.97
Forskolin induced chloride secretion across the isolated mucosa of rat colon descendens. Naunyn Schmiedebergs Arch Pharmacol (1983) 0.97
Should we routinely screen for cytomegalovirus antibody during pregnancy? Intervirology (1998) 0.97
Biologic effects of epidermal growth factor in human fetal jejunum. Gastroenterology (1988) 0.97
Requirement for omega and (omega;-1)-hydroxylations of fatty acids by human cytochromes P450 2E1 and 4A11. J Lipid Res (1999) 0.97
Detection and molecular characterization of enteric viruses in environmental samples in Monastir, Tunisia between January 2003 and April 2007. J Appl Microbiol (2010) 0.96
[Investigations on the length of action of ranitidine (author's transl)]. Dtsch Med Wochenschr (1980) 0.96
Cloning, sequence and chromosomal location of a MEL gene from Saccharomyces carlsbergensis NCYC396. Gene (1991) 0.96
The burden of norovirus gastroenteritis: an important foodborne and healthcare-related infection. Clin Microbiol Infect (2014) 0.95
Survey of human rotavirus propagation as studied by electrophoresis of genomic RNA. J Infect Dis (1984) 0.95
Monoclonal antibodies to the major capsid protein of human papillomavirus type 1. J Gen Virol (1984) 0.95
High-resolution three-dimensional tomographic diffractive microscopy of transparent inorganic and biological samples. Opt Lett (2009) 0.95
Management of nonfunctioning islet cell carcinomas. World J Surg (2000) 0.94
Localization of group-specific epitopes on the major capsid protein of group A rotavirus. J Gen Virol (1992) 0.94
Immunological and biological properties of Bet v 4, a novel birch pollen allergen with two EF-hand calcium-binding domains. J Biol Chem (1997) 0.94
[Sensitivity and specificity of the VIKIA Rota-Adeno immuno-chromatographic test (bioMérieux) and the ELISA IDEIA Rotavirus kit (Dako) compared to genotyping]. Pathol Biol (Paris) (2008) 0.94
Location of the 11 bp exon in the chicken pro alpha 2(I) collagen gene. Nucleic Acids Res (1984) 0.94
Unusual DNA sequences located within the promoter region and the first intron of the chicken pro-alpha 1(I) collagen gene. J Biol Chem (1987) 0.93
On the specificity of human anti-H antibodies. Vox Sang (1986) 0.93